Nutex Health: The Stock Has Had A Great Run, But New Guidance Justifies A Higher Target Price (Rating Upgrade)
Nutex Health raises its target price to $290.43 as FY2026 EPS consensus reaches $27.79, leaving NUTX at 10.5 times forward earnings.
Adam Schadt 5 clicks